Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GALECTIN THERAPEUTICS INC.

(GALT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

GALECTIN THERAPEUTICS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

09/13/2021 | 07:02am EDT

Item 7.01 Regulation FD Disclosure.

On September 13, 2021, Galectin Therapeutics Inc. (the "Company) posted to its website a presentation which is attached hereto as Exhibit 99.1.

The information in this report is being furnished pursuant to this Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, and it shall not be deemed incorporated by reference in any filing under the Securities Act of 1933 or under the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to this report.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit Number        Description

99.1                    Corporate Overview Presentation, September 2021

104                   Cover Page Interactive Data File (embedded within the Inline
                      XBRL document).




                                     - 2 -

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about GALECTIN THERAPEUTICS INC.
10/06GALECTIN THERAPEUTICS : to Participate in the H.C. Wainwright 5th Annual NASH Investor Con..
AQ
10/05UPDATE : Galectin Therapeutics to Participate in the H.C. Wainwright 5th Annual NASH Inves..
GL
10/05UPDATE : Galectin Therapeutics to Participate in the H.C. Wainwright 5th Annual NASH Inves..
GL
10/05GALECTIN THERAPEUTICS : to Participate in the H.C. Wainwright 23rd Annual Global Investmen..
AQ
09/21GALECTIN THERAPEUTICS : Secures $20 Million Debt Financing from Chairman Richard Uihlein
MT
09/21GALECTIN THERAPEUTICS : Announces $20 Million Convertible Debt Financing from Its Chairman..
PU
09/21GALECTIN THERAPEUTICS : Announces $20 Million Convertible Debt Financing from Its Chairman..
AQ
09/21GALECTIN THERAPEUTICS INC : Entry into a Material Definitive Agreement, Creation of a Dire..
AQ
09/17Galectin Therapeutics Inc. announced that it expects to receive $20 million in funding
CI
09/13GALECTIN THERAPEUTICS INC : Regulation FD Disclosure, Financial Statements and Exhibits (f..
AQ
More news
Analyst Recommendations on GALECTIN THERAPEUTICS INC.
More recommendations